Articles & Blogs Pharma & Life Sciences
Tuesday, 25 October 2016
A baby boy which has genetic material from three adults has been born.
The Government has announced that community pharmacy funding will be cut by 4% for 2016-2017 and 3.4% for 2017-2018 - an overall reduction in funding to approximately £2.592bn.
Scientists have unveiled a new test that is akin to a smoke detector that would spot cancer before symptoms arise.
Tuesday, 11 October 2016
Seemingly no pharma company is left safe from takeover this year, as we see Bayer seek to branch out into the agri-chemical space through its proposed takeover of Monsanto.
Software that analyses health data could be deemed to be a medical device and become regulated, the Medicines and Healthcare products Regulatory Agency (MHRA) has said.
Microsoft has announced that it plans to 'solve' cancer in the next 10 years by treating it as a computer virus.
For only the fourth time in its history, the UN general assembly has held a high-level meeting on a health issue and this time its focus was on antimicrobial resistance.
Wednesday, 28 September 2016
Community pharmacy contributed £3 billion to the NHS, public sector and wider society in England in 2015, according to a report from PwC.
With US pharmaceutical giant Pfizer looking set to take over swathes of the pharmaceutical industry with its multiple acquisition attempts.
Mark Zuckerberg and his wife, Priscilla Chan, have announced that they are committing a huge US$3bn to medical research through the Chan Zuckerberg Initiative
The Community Pharmacy Forward View has finally been published to the delight of many in the pharmacy sector.
Pharma & Life Sciences
Monday, 16 January 2017
Scientists in Switzerland have successfully treated two rhesus monkeys which each had one leg paralysed due to a partial spinal cord lesion using new technology to allow them to walk once more.
Brexit Articles & Blogs Pharma & Life Sciences
Tuesday, 30 August 2016
AstraZeneca has announced its commitment to spending £330million on a new research and development centre in Cambridge
The Brexit vote has sent shockwaves through the science community.
One of the big questions facing the pharmaceuticals and life sciences and healthcare sectors is: what to do about the growing resistance of superbugs to antibiotics?